Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial. (2022)
Attributed to:
The Durability of immune Responses to vaccination against SARS-CoV-2 and its Variants.
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2213-2600(22)00186-2
PubMed Identifier: 35772416
Publication URI: http://europepmc.org/abstract/MED/35772416
Type: Journal Article/Review
Volume: 10
Parent Publication: The Lancet. Respiratory medicine
Issue: 9
ISSN: 2213-2600